Clinical Trials · NCT02085252
A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 116
- Start date
- Jun 2013
- Locations
- 2 sites, France
- Primary endpoint
- Number of Participants With Negative Biopsies at Month 12